2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Chiabrando C et al. | Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry. | 1989 | J. Chromatogr. | pmid:2613794 |
Förstermann U et al. | An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A. | 1989 | Prostaglandins | pmid:2662262 |
Grèen K et al. | Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). | 1989 | Prostaglandins | pmid:2664901 |
Rousson D et al. | Increased in vivo biosynthesis of prostacyclin and thromboxane A2 in chronic idiopathic thrombocytopenic purpura. | 1989 | Br. J. Haematol. | pmid:2669929 |
Kühl PG et al. | Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension. | 1989 | Arch. Dis. Child. | pmid:2673060 |
Barrow SE et al. | Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. | 1989 | Biochim. Biophys. Acta | pmid:2679889 |
pmid:27137142 | ||||
Aitokallio-Tallberg A et al. | Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment. | 1989 | Br. J. Cancer | pmid:2803956 |
Gréen K et al. | Deficient prostacyclin formation after acute myocardial infarction. | 1987 | Lancet | pmid:2883378 |
Edlund A et al. | Myocardial ischaemia triggers formation of thromboxane. | 1987 | Lancet | pmid:2887865 |
Fischer C and Meese CO | Simultaneous determination of 6-oxo-prostaglandin F1 alpha and 2,3-dinor-6-oxo-prostaglandin F1 alpha in biological fluids by stable isotope dilution and negative ion chemical ionization mass spectrometry. | 1985 | Biomed. Mass Spectrom. | pmid:2931130 |
Reilly IA et al. | Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. | 1986 | Circulation | pmid:2938849 |
Gréen K and Vesterqvist O | In vivo synthesis of thromboxane and prostacyclin in man in health and disease. Data from GC-MS measurements of major urinary metabolites. | 1986 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2949557 |
Gréen K and Vesterqvist O | In vivo synthesis of thromboxane A2 and prostaglandin I2 in healthy and diseased individuals. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959096 |
Edlund A et al. | Leg exercise increases prostacyclin synthesis without activating platelets in both healthy and atherosclerotic humans. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959097 |
Ciabattoni G et al. | Radioimmunoassay measurement of 2,3-dinor metabolites of prostacyclin and thromboxane in human urine. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960163 |
Castagnoli MN et al. | Combined high-performance liquid chromatography and enzyme immunoassay for the determination of urinary metabolites of thromboxane and 6-keto-PGF1 alpha. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960164 |
Ylikorkala O et al. | Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins. | 1987 | J. Clin. Endocrinol. Metab. | pmid:2960690 |
Knapp HR et al. | In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. | 1986 | N. Engl. J. Med. | pmid:3007982 |
Balazy M et al. | Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. | 1988 | Prostaglandins | pmid:3070630 |